A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout: Was its Withdrawal from the Market in the Best Interest of Patients?
Year: 2008
Type: article
Source: Drug Safety
Institutions: UNSW Sydney, St Vincent's Hospital Sydney
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2036508585
